To continue using this website, please tell us a
little about yourself:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here




It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: Announcement

Friday 09 March, 2012

RNS Number : 0485Z
Irish Takeover Panel
09 March 2012


Disclosure Table

The following companies are deemed to be in an offer period for the purposes of disclosure under the Rules of the Irish Takeover Panel:


Offeree:   Merrion Pharmaceuticals plc


Offer period commenced:    20 October 2011


€0.01 ordinary shares, ISIN: IE00B282VY28, NSI: 17,131,509


Offeror:   No named Offeror



Offeree:   Readymix plc


Offer period commenced:    19 January 2012


€0.12 ordinary shares, ISIN: IE0007267820, NSI: 109,645,169


Offeror:   Readymix Investments, a wholly owned

                subsidiary of Cemex Espana S.A.


Disclosure of interests and dealings in the relevant securities of the above offeror is not required.



Irish Takeover Panel                                                 9 March 2012

Lower Ground Floor

76 Merrion Square

Dublin 2


Telephone: 353-1-6789020                                        Fax: 353-1-6789289




This information is provided by RNS
The company news service from the London Stock Exchange
Data provided by FE. Care has been taken to ensure that the information is correct, but FE neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.